Telemonitoring of Hypertensive Patients

NCT01743170 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2020-03-03

No results posted yet for this study

Summary

The proportion of hypertensive patients achieving adequate blood pressure control meeting guideline targets remains low. Of hypertensive patients, only 50% are on antihypertensive medications. Of those on blood pressure lowering drugs, only 50% have their blood pressure controlled.

The objectives of this study are:

1. To test the feasibility of telemonitoring of blood pressure in Flemish general practices.
2. To investigate in a randomized fashion whether telemonitoring enabled self-measurement of blood pressure leads to faster blood pressure control than self-measurement without the telemonitoring information.
3. The secondary endpoints include various blood pressure indexes, adverse effects, a simple assessment of quality of life, adherence, a log of technical problems, and cost effectiveness (EQ-5D-5L).

Conditions

Interventions

OTHER

Telemonitoring of self-measured blood pressure

In the intervention group, doctors receive weekly reports via telemonitoring on the self-measured blood pressure

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Jan A Staessen, MD, PhD · University of Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-07-31
Completion
2022-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01743170 on ClinicalTrials.gov